Literature DB >> 4047494

Glutathione peroxidase activity in Parkinson's disease brain.

S J Kish, C Morito, O Hornykiewicz.   

Abstract

Glutathione peroxidase is an enzyme of major importance in the detoxification of peroxides in brain. Using the spectrophotometric procedure of Paglia and Valentine [8] and Beutler [2] we measured the activity of this enzyme in autopsied brain from 12 patients dying with idiopathic Parkinson's disease and 11 neurologically normal adults matched with respect to age and postmortem interval. In the Parkinson's disease patients glutathione peroxidase activity was slightly but significantly reduced in several brain areas including substantia nigra. Although the magnitude of the glutathione peroxidase deficiency in Parkinson's disease substantia nigra was small (19% reduction), coupled with the reported marked deficiency of reduced glutathione [9] it may represent one of the contributing factors leading to nigral dopamine neurone loss.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4047494     DOI: 10.1016/0304-3940(85)90078-3

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  46 in total

1.  The role of oxidative stress in amyotrophic lateral sclerosis and Parkinson's disease.

Authors:  Athan Baillet; Vanessa Chanteperdrix; Candice Trocmé; Pierre Casez; Catherine Garrel; Gérard Besson
Journal:  Neurochem Res       Date:  2010-06-10       Impact factor: 3.996

2.  Sustained extracellular signal-regulated kinase activation by 6-hydroxydopamine: implications for Parkinson's disease.

Authors:  S M Kulich; C T Chu
Journal:  J Neurochem       Date:  2001-05       Impact factor: 5.372

Review 3.  Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences.

Authors:  Nicole Exner; Anne Kathrin Lutz; Christian Haass; Konstanze F Winklhofer
Journal:  EMBO J       Date:  2012-06-26       Impact factor: 11.598

Review 4.  Transplantation into the human brain: present status and future possibilities.

Authors:  O Lindvall
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-06       Impact factor: 10.154

Review 5.  L-DOPA treatment from the viewpoint of neuroprotection. Possible mechanism of specific and progressive dopaminergic neuronal death in Parkinson's disease.

Authors:  Norio Ogawa; Masato Asanuma; Ikuko Miyazaki; Francisco J Diaz-Corrales; Ko Miyoshi
Journal:  J Neurol       Date:  2005-10       Impact factor: 4.849

6.  Glutathione peroxidase in early and advanced Parkinson's disease.

Authors:  P Johannsen; G Velander; J Mai; E B Thorling; E Dupont
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-08       Impact factor: 10.154

Review 7.  Oxidative stress in Parkinson's disease: a mechanism of pathogenic and therapeutic significance.

Authors:  Chun Zhou; Yong Huang; Serge Przedborski
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

8.  Reactive oxygen species and reactive nitrogen species: relevance to cyto(neuro)toxic events and neurologic disorders. An overview.

Authors:  D Metodiewa; C Kośka
Journal:  Neurotox Res       Date:  2000-02       Impact factor: 3.911

Review 9.  Clues to the mechanism underlying dopamine cell death in Parkinson's disease.

Authors:  P Jenner
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-06       Impact factor: 10.154

10.  An open-randomized clinical trial of selegiline in amyotrophic lateral sclerosis.

Authors:  L Mazzini; D Testa; C Balzarini; G Mora
Journal:  J Neurol       Date:  1994-02       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.